<?xml version="1.0" encoding="UTF-8"?>
<results title="activity">
 <result pre="The pharmacological impacts of these compounds include anti-peptic ulcer effect," exact="antimicrobial" post="effect, anti-oxidative effect, anti-inflammatory effect, effect on ischemia/reperfusion injury,"/>
 <result pre="these compounds include anti-peptic ulcer effect, antimicrobial effect, anti-oxidative effect," exact="anti-inflammatory" post="effect, effect on ischemia/reperfusion injury, analgesic effect, antitumor effect,"/>
 <result pre="antimicrobial effect, anti-oxidative effect, anti-inflammatory effect, effect on ischemia/reperfusion injury," exact="analgesic" post="effect, antitumor effect, antidiabetic effect, anti-hypertensive effect, immunoregulatory effect,"/>
 <result pre="anti-inflammatory effect, effect on ischemia/reperfusion injury, analgesic effect, antitumor effect," exact="antidiabetic" post="effect, anti-hypertensive effect, immunoregulatory effect, and others.For this review,"/>
 <result pre="has been most intensively studied in the pharmacological effects including" exact="anti-inflammatory" post="effect, anti-apoptotic effect, anti-oxidative effect, anti-tumor effect, and others."/>
 <result pre="study in the same year demonstrated that PA could exert" exact="analgesic" post="effect by regulating opioid receptors [18]. Furthermore, PA could"/>
 <result pre="PA, pogostone has been reported to possess gastroprotective, anti-photoaging, and" exact="antimicrobial" post="properties. Furthermore, a research in 2017 found that pogostone"/>
 <result pre="ÂµM, respectively). Notably, Patchouliguaiol C and Patchouliguaiol F also exhibited" exact="antifungal" post="activity against Candida albicans, with minimum inhibitory concentrations (MICs)"/>
 <result pre="X-ray Sesquiterpenoids Vasorelaxant activity against PHE-induced contraction (EC50â€‰=â€‰5.4 ÂµM) [38]" exact="Antifungal" post="activity against Candida albicans (MICâ€‰=â€‰500 ÂµM) Patchouliguaiol D C15H22O"/>
 <result pre="ÂµM) [38] Vasorelaxant activity against KCl- induced contraction (EC50â€‰=â€‰24.2 ÂµM)" exact="Antifungal" post="activity against Candida albicans (MICâ€‰=â€‰300 ÂµM) Patchouliguaiol G C15H24O2"/>
 <result pre="this disease [45], most notably the chronic use of nonsteroidal" exact="anti-inflammatory" post="drugs [46]. Moreover, pro-inflammatory cytokines, including tumor necrosis factor-Î±"/>
 <result pre="of malondialdehyde (MDA) in rat models of disease. Levels of" exact="prostaglandin" post="E2 (PGE2) and the protein and relative mRNA expression"/>
 <result pre="the suppression of MDA in gastric tissues. Furthermore, PAO exhibited" exact="anti-inflammatory" post="activity as it coordinated the production of both pro-"/>
 <result pre="activity as it coordinated the production of both pro- and" exact="anti-inflammatory" post="cytokines by its capacity to regulate the expression of"/>
 <result pre="administration of PA also resulted in the suppression of several" exact="anti-inflammatory" post="cytokines, including IL-4 and IL-10. UC-associated cellular pathology is"/>
 <result pre="is a critical pharmacological agent isolated from patchouli that exhibits" exact="antimicrobial" post="activity against H. pylori both in vitro and in"/>
 <result pre="this reduces the UreB protein level and thus facilitates macrophage-mediated" exact="antimicrobial" post="activity [67]. PA also promotes direct cytoprotective effects and"/>
 <result pre="Recent studies [68] revealed that PA could also reverse the" exact="cytotoxicity" post="for gastric epithelial cells (GES-1) that results from an"/>
 <result pre="both SOD and CAT. As such, PA serves as an" exact="anti-inflammatory agent" post="by eliminating H. pylori and inhibiting the expression of"/>
 <result pre="pharmacological mechanisms of PA on H. pylori-induced gastric ulcer Other" exact="antimicrobial" post="effect Earlier studies identified numerous antimicrobial activities associated with"/>
 <result pre="pylori-induced gastric ulcer Other antimicrobial effect Earlier studies identified numerous" exact="antimicrobial" post="activities associated with the use of patchouli [7]; among"/>
 <result pre="an MIC of 31.25Â mg/mL [72]. In addition, PO has" exact="antimicrobial" post="activities against both Gram-positive and Gram-negative microorganisms, with an"/>
 <result pre="[81]. NF-E2-related factor-2 (Nrf2) is a transcription factor that activates" exact="antioxidant" post="response elements to regulate the expression of a variety"/>
 <result pre="antiapoptotic proteins [82]. Previous studies revealed that PO exhibits significant" exact="antioxidant" post="potential, by actions that promote the elimination of superoxide"/>
 <result pre="of this effect relates to the amplification of the endogenous" exact="antioxidant" post="defense system via the ERK1/2-dependent activation of Nrf2 [34]."/>
 <result pre="in mouse model systems; it promoted the activities of the" exact="antioxidant" post="enzymes, including CAT, SOD, and GSH-PX, downregulated MDA levels,"/>
 <result pre="nitric oxide (NO), and PGE2, among others [97]. As such," exact="agents" post="capable of regulating inflammation by the synthesis and release"/>
 <result pre="mediates inflammation initiated by macrophage responses [98]. Î²-PAE exhibits significant" exact="anti-inflammatory" post="effect on LPS-stimulated RAW 264.7 macrophages by its capacity"/>
 <result pre="by its capacity to maintain the balance between pro- and" exact="anti-inflammatory" post="cytokine production [99]. Pretreatment with Î²-PAE results in significantly"/>
 <result pre="to find that aged preparations enriched in PAO also exhibit" exact="anti-inflammatory" post="effect. The administration of PAO resulted in decreased levels"/>
 <result pre="inflammation. As the oxidative product of Î²-PAE, PAO exerted potent" exact="anti-inflammatory" post="activities in vivo, which included the decreased expression of"/>
 <result pre="IL-12, IL-1Î², and monocyte chemotactic protein-1 (MCP-1). In addition, the" exact="anti-inflammatory" post="effect of PAO were superior to those of Î²-PAE"/>
 <result pre="via their corresponding iNOS and COX-2 signaling pathways [103]. The" exact="anti-inflammatory" post="effect of PO were also examined; this agent served"/>
 <result pre="cytokines [104]. The pharmacological activities of patchouli with respect to" exact="anti-inflammatory" post="responses are presented in TableÂ 4. Table 4 Pharmacological"/>
 <result pre="(pain) in mice; these results implied that patchouli exhibits an" exact="analgesic" post="effect in vivo [108]. COX-2, an inflammatory cyclooxygenase, is"/>
 <result pre="to the development of zebrafish embryos; among the findings, these" exact="agents" post="were associated with an increased incidence of notochord malformation"/>
 <result pre="and mechanisms of action of patchouli, including anti-peptic ulcer effect," exact="antimicrobial" post="effect, anti-oxidative effect, anti-inflammatory effect, I/R injury protection, analgesic"/>
 <result pre="of patchouli, including anti-peptic ulcer effect, antimicrobial effect, anti-oxidative effect," exact="anti-inflammatory" post="effect, I/R injury protection, analgesic effect, antitumor effect, antidiabetic"/>
 <result pre="effect, antimicrobial effect, anti-oxidative effect, anti-inflammatory effect, I/R injury protection," exact="analgesic" post="effect, antitumor effect, antidiabetic effect, anti-hypertensive effect, immunoregulatory effect,"/>
 <result pre="effect, anti-inflammatory effect, I/R injury protection, analgesic effect, antitumor effect," exact="antidiabetic" post="effect, anti-hypertensive effect, immunoregulatory effect, effect on intestinal microecology,"/>
 <result pre="others. Results from multiple studies demonstrated that patchouli and its" exact="derivatives" post="can promote protective effects on the stomach, intestines, liver,"/>
 <result pre="in the near future. Pharmacological studies of patchouli and its" exact="derivative" post="compounds have been performed primarily in vitro and in"/>
 <result pre="LRR, and PYD domain-containing protein 3 NO Nitric oxide PGE2" exact="Prostaglandin" post="E2 TNF-Î± Tumor necrosis factor-Î± IL-6 Interleukin-6 IL-1Î² Interleukin-1"/>
 <result pre="Sci200943351925 34.KimEKKimJHJeongSChoiYWKimY-MPachypodol, a methoxyflavonoid isolated from Pogostemon cablin bentham exerts" exact="antioxidant" post="and cytoprotective effects in HepG2 cells: possible role of"/>
 <result pre="Mol Ences201920408210.3390/ijms20174082 35.HuangXJLiPYinZQLuJJLinLGWangYYeWCZhangQWCablinosides A and B, two glycosidic phenylacetic acid" exact="derivatives" post="from the leaves of Pogostemon cablinChem Biodiv.2019165e190013710.1002/cbdv.201900137 36.LiuJLLiXhPengCLinDSWangYNYangYTZhouQMXiongL4-nor-Î²-Patchoulene sesquiterpenoids"/>
 <result pre="injuryEntific Reports201775591 52.XavierRJPodolskyDKUnravelling the pathogenesis of inflammatory bowel diseaseNature20074484273410.1038/nature0600517653185 53.ImpellizzeriDBruschettaGPaolaRDAhmadACampoloMCuzzocreaSEspositoENavarraMThe" exact="anti-inflammatory" post="and antioxidant effects of bergamot juice extract (BJe) in"/>
 <result pre="52.XavierRJPodolskyDKUnravelling the pathogenesis of inflammatory bowel diseaseNature20074484273410.1038/nature0600517653185 53.ImpellizzeriDBruschettaGPaolaRDAhmadACampoloMCuzzocreaSEspositoENavarraMThe anti-inflammatory and" exact="antioxidant" post="effects of bergamot juice extract (BJe) in an experimental"/>
 <result pre="Clin Exp Med20161521914 96.GhorbanzadehBMansouriMTHemmatiAANaghizadehBMardSARezaieAA study of the mechanisms underlying the" exact="anti-inflammatory" post="effect of ellagic acid in carrageenan-induced paw edema in"/>
 <result pre="Wu JZ, Huang QH, Li YC, Xie QF. Comparison of" exact="anti-inflammatory" post="effect between Î²-patchoulene epoxide and Î²-patchoulene in LPS-stimulated RAW264.7"/>
 <result pre="J Ethnomed Ethnopharm201524146 144.PengFXieXPengCChinese herbal medicine-based cancer therapy: novel anticancer" exact="agents" post="targeting microRNAs to regulate tumor growth and metastasisAm J"/>
 <result pre="to regulate tumor growth and metastasisAm J Chin Med201947817113510.1142/S0192415X1950087331801358 145.PengFXiongLXieXTangHHuangRPengCIsoliquiritigenin" exact="derivative" post="regulates miR-374a/BAX axis to suppress triple-negative breast cancer tumorigenesis"/>
 <result pre="augments the skin anti-photoaging properties of Agastache rugosa through up-regulating" exact="antioxidant" post="components in UV-B-irradiated HaCaT keratinocytesBMC Complement Altern Med201818119610.1186/s12906-018-2194-929940937 151.LeeTHParkSYooGJangCKimMHKimSHKimSYDemethyleugenol"/>
 <result pre="Agric Food Chem2016644177334210.1021/acs.jafc.6b0325627673705 152.ShinSEssential oil compounds from Agastache rugosa as" exact="antifungal" post="agents against Trichophyton speciesArch Pharm Res2004273295910.1007/BF0298006315089034 153.HaiyanGLijuanHShaoyuLChenZAshrafMAAntimicrobial, antibiofilm and"/>
 <result pre="Food Chem2016644177334210.1021/acs.jafc.6b0325627673705 152.ShinSEssential oil compounds from Agastache rugosa as antifungal" exact="agents" post="against Trichophyton speciesArch Pharm Res2004273295910.1007/BF0298006315089034 153.HaiyanGLijuanHShaoyuLChenZAshrafMAAntimicrobial, antibiofilm and antitumor"/>
 <result pre="Xinjiang, ChinaSaudi J Biol Sci20162345243010.1016/j.sjbs.2016.02.02027298587 154.DestaKTKimGSKimYHLeeWSLeeSJJinJSAbd El-AtyAMShinHCShimJHShinSCThe polyphenolic profiles and" exact="antioxidant" post="effects of Agastache rugosa Kuntze (Banga) flower, leaf, stem"/>
</results>
